DCF — INTEGRIS SOUTHWEST MEDICAL CENTER
Enterprise Value: $-555.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-555.8M
Enterprise Value
$-173.4M
PV of Cash Flows
$-382.4M
PV of Terminal Value
$-615.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $275.6M | $-35.9M | -13.0% | $-47.6M | $-43.3M |
| Year 2 | $283.9M | $-34.2M | -12.0% | $-46.2M | $-38.2M |
| Year 3 | $292.4M | $-32.3M | -11.0% | $-44.7M | $-33.6M |
| Year 4 | $301.2M | $-31.7M | -11.0% | $-44.5M | $-30.4M |
| Year 5 | $310.2M | $-31.9M | -10.0% | $-45.1M | $-28.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-555.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$267.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13541010391874536
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5